{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T13:24:36Z","timestamp":1648646676937},"reference-count":6,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":3128,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1157\/13080308","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T07:56:51Z","timestamp":1130486211000},"page":"406-407","source":"Crossref","is-referenced-by-count":0,"title":["Indicaciones autorizadas en Espa\u00f1a de los f\u00e1rmacos antiosteopor\u00f3ticos"],"prefix":"10.1016","volume":"36","author":[{"given":"A.","family":"\u00dabeda","sequence":"first","affiliation":[]},{"given":"L.","family":"Monz\u00f3n","sequence":"additional","affiliation":[]},{"given":"F.","family":"Fern\u00e1ndez-Llim\u00f3s","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1157\/13080308_bib1","series-title":"Osteoporosis. SECOT","year":"2004"},{"key":"10.1157\/13080308_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/8756-3282(94)90280-1","article-title":"Epidemiology and clinical features of osteoporosis in young individuals","volume":"15","author":"Khosla","year":"1994","journal-title":"Bone"},{"key":"10.1157\/13080308_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0149-2918(04)90002-1","article-title":"Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment","volume":"26","author":"Olszynski","year":"2004","journal-title":"Clin Ther"},{"key":"10.1157\/13080308_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.1075","article-title":"The population risk of fractures attributable to oral corticosteroids","volume":"14","author":"Donnan","year":"2005","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1157\/13080308_bib5","unstructured":"Real Decreto 223\/2004, de 6 de febrero, por el que se regulan los ensayos cl\u00ednicos con medicamentos. Madrid: BOE de 7 de febrero de 2004."},{"key":"10.1157\/13080308_bib6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","article-title":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update","volume":"44","year":"2001","journal-title":"Arthritis Rheum"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656705705278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656705705278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T13:29:27Z","timestamp":1548077367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656705705278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0212656705705278"],"URL":"https:\/\/doi.org\/10.1157\/13080308","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}